INTRECATE

Serial Number 97087466
733

Registration Progress

Application Filed
Oct 22, 2021
Under Examination
May 16, 2023
Approved for Publication
Mar 21, 2023
Published for Opposition
Mar 21, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Nov 16, 2025 118 days

Trademark Image

INTRECATE

Basic Information

Serial Number
97087466
Filing Date
October 22, 2021
Published for Opposition
March 21, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
May 14, 2025
Application
Pending
Classes
005

Rights Holder

Intrecate Biotherapeutics, Inc.

03
Address
c/o Foley Hoag LLP
155 Seaport Blvd.
Boston, MA 022102600

Ownership History

Intrecate Biotherapeutics, Inc.

Original Applicant
03
Boston, MA

Intrecate Biotherapeutics, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Nicole Kinsley, Esq.

USPTO Deadlines

Next Deadline
118 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
November 16, 2025
Extension Available
Until May 16, 2024

Application History

34 events
Date Code Type Description Documents
May 14, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 14, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 3, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 3, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 3, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 22, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 6, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 6, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 18, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 16, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 10, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 2, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 2, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 8, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 26, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Additional Information

Pseudo Mark
INTRICATE

Classification

International Classes
005